{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

        
User account menu
Main navigation
  • Topics
    • Customer Care
    • Regulated Industries
    • Research & Tech
    • Quality Improvement Tools
    • People Management
    • Metrology
    • Manufacturing
    • Roadshow
    • QMS & Standards
    • Statistical Methods
    • Resource Management
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • Customer Care
    • Regulated Industries
    • Research & Tech
    • Quality Improvement Tools
    • People Management
    • Metrology
    • Manufacturing
    • Roadshow
    • QMS & Standards
    • Statistical Methods
    • Supply Chain
    • Resource Management
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Contact
    • Training

CRO Completes Multinational Training Program for Principal Investigators from China, Duke University

Clinical Research Consulting Inc.
Tue, 04/22/2008 - 22:00
  • Comment
  • RSS

Social Sharing block

  • Print
Body

Lisa Mazurka and the clinical investigators involved in the training is available

(Clinical Research Consulting Inc.: Boston, Massachusetts) -- Clinical Research Consulting Inc., a contract research organization (CRO) specializing in clinical monitoring, project management, education and training, has completed training for investigators involved in an investigator-sponsored study led by Duke University in conjunction with the Beijing Cancer Hospital and Peking University. Six investigators from Beijing joined investigators and other research personnel from Duke for the one-and-a-half-day training session led by Lisa Mazurka, president of CRC.

The formal training session was conducted at the Duke Comprehensive Cancer Center, in Durham, North Carolina, and covered Food and Drug Administration regulations, good clinical practice guidelines, and additional topics that are imperative to investigators such as informed consent, investigator responsibilities, protocol compliance, adverse events, documentation, noncompliance, fraud, and FDA suspension.

 …

Want to continue?
Log in or create a FREE account.
Enter your username or email address
Enter the password that accompanies your username.
By logging in you agree to receive communication from Quality Digest. Privacy Policy.
Create a FREE account
Forgot My Password
Top Stories
What FDA Warning Letters Reveal About Records, Spreadsheets, and AI
ISO 9001:2026 Ethics and Quality Culture
The Art of Forecasting: Part 1
Avoiding the 7 Deadly Killers of Projects
ISO 9001:2026 Is Here

Add new comment

Please login to comment.

© 2026 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us
  • Contact Us